Tag: Patient Safety

The Munro Scale: Journey from conception to validity and reliability

After a journey of more than 20 years, validity and reliability studies for the Munro Pressure Injury Risk Assessment Scale for Perioperative Patients (Munro Scale) show that the Munro Scale works. The Munro Scale, created by Cassendra A. Munro, PhD, MSN, RN, RNFA, CNOR, is the first standard tool that…

Read More

By: Judith M. Mathias, MA, BS, RN
June 28, 2022
Share

FDA: Class I recall of Medtronic’s HVAD batteries

Editor's Note The Food and Drug Administration (FDA), on June 23, identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) batteries as Class I, the most serious. The recall for a single lot (Model Number:1650DE) of HVAD batteries was initiated because of welding defects that allow separation…

Read More

By: Judy Mathias
June 27, 2022
Share

The Joint Commission: New R3 Report on reducing healthcare disparities

Editor's Note The Joint Commission on June 22 announced a new “R3 Report—Issue 36: New Requirements to Reduce Health Care Disparities,” which examines the rationale and references behind new and revised requirements to reduce healthcare disparities in accredited organizations, effective January 1, 2023. Among the new and revised requirements: A…

Read More

By: Judy Mathias
June 23, 2022
Share

FDA: Class I recall of one lot of Draeger SafeStar 55 Breathing System Filters

Editor's Note The Food and Drug Administration (FDA) on June 21 identified the recall by Draeger, Inc, of one lot (LT2103) of its SafeStar 55 Breathing System Filters as Class I, the most serious. The Breathing System Filter is used as part of a ventilator when a patient is under…

Read More

By: Judy Mathias
June 22, 2022
Share

Study: Best way to test for COVID-19 is nasopharyngeal swab

Editor's Note This study by researchers from Cornell University finds that nasopharyngeal swabs taken from back inside the nostril were more effective at detecting COVID-10 than saliva tests or swabs just inside the nostril or under the tongue. Comparing different samples from 77 patients, the researchers found that: Nasopharyngeal samples…

Read More

By: Judy Mathias
June 15, 2022
Share

FDA: Class I recall of Medtronic HVAD Pump Implant Kit

Editor's Note The Food and Drug Administration (FDA) on June 8 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit as Class I, the most serious. The HVAD System is used as a bridge to cardiac transplants. The Kit was recalled because of a…

Read More

By: Judy Mathias
June 9, 2022
Share

Protection, waning of immunity to COVID-19 after infection, vaccination

Editor's Note This Israeli study finds that individuals previously infected with COVID-19, regardless of whether they had been vaccinated, had more protection against reinfection than those who were vaccinated (Pfizer-BioNTech vaccine) but previously uninfected. Among the findings for the number of COVID-19 cases per 100,000 person days since vaccination or…

Read More

By: Judy Mathias
June 8, 2022
Share

FDA: Class I recall of Philips Respironics V60, V60 Plus Ventilators

Editor's Note The Food and Drug Administration on June 3 identified the recall by Philips Respironics of all V60 and V60 Plus Ventilators as Class I, the most serious. The recall was initiated because an internal power fluctuation may cause the ventilator to shut down unintentionally with or without any…

Read More

By: Judy Mathias
June 8, 2022
Share

FDA: Class I recall of Atrium Medical’s iCast Covered Stent

Editor's Note The Food and Drug Administration (FDA) on June 2 identified the recall by Atrium Medical Corporation of its iCast Covered Stent System as Class I, the most serious. The recall was initiated because of increased complaints about the separation of the balloon or catheter hub from the delivery…

Read More

By: Judy Mathias
June 7, 2022
Share

Changes in cancer screening during COVID-19

Editor's Note  This study from the American Cancer Society, Atlanta, finds that the prevalence of breast, cervical, and colorectal cancer screening decreased during COVID-19. A total of 479,248 patients were included in the analysis for breast cancer screening, 301,453 for cervical cancer screening, and 854,210 for colorectal cancer screening. Between…

Read More

By: Judy Mathias
June 6, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat